99mTechnetium-based Prostate-specific Membrane Antigen-radioguided Surgery in Recurrent Prostate Cancer.

@article{Maurer201899mTechnetiumbasedPM,
  title={99mTechnetium-based Prostate-specific Membrane Antigen-radioguided Surgery in Recurrent Prostate Cancer.},
  author={Tobias Maurer and Stephanie Robu and Margret Schottelius and Kristina Schwamborn and Isabel Rauscher and Nynke Sjoerdtje van den Berg and Fijs W. B. van Leeuwen and Bernhard Haller and Thomas R Horn and Matthias Michael Heck and J{\"u}rgen Erich Gschwend and Markus Schwaiger and H J Wester and Matthias Eiber},
  journal={European urology},
  year={2018}
}
BACKGROUND Prostate-specific membrane antigen (PSMA)-targeted positron emission tomography (PET) can visualize metastatic lesions in recurrent prostate cancer (PC). However, reliable identification of small and/or atypically localized lesions during salvage surgery procedures is challenging. OBJECTIVE To describe the technique, feasibility, and short-term outcomes of 99mTechnetium (99mTc)-based PSMA-radioguided surgery (99mTc-PSMA-RGS) for removal of recurrent PC lesions. DESIGN, SETTING… CONTINUE READING
Related Discussions
This paper has been referenced on Twitter 42 times. VIEW TWEETS